Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09DX03	OLMENOR TRIPLE	G	Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 10mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	1,067,011 L.L
C09DX03	OLMENOR TRIPLE	G	Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 10mg, Hydrochlorothiazide - 25mg		Tablet, film coated	1,067,011 L.L
C09DX03	OLMENOR TRIPLE	G	Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 5mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	1,067,011 L.L
C09DX03	OLMENOR TRIPLE	G	Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 5mg, Hydrochlorothiazide - 25mg		Tablet, film coated	1,067,011 L.L
C09DB02	OLMENOR COMBI	G	Olmesartan medoxomil - 40mg, Amlodipine - 5mg		Tablet, film coated	772,709 L.L
C09DA08	OLMENOR PLUS	G	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	653,107 L.L
C09DA08	OLMENOR PLUS	G	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 25mg		Tablet, film coated	653,107 L.L
S01GX09	OLOHISTINE	G	Olopatadine (HCl) - 0.1%	0.1%	Solution	522,755 L.L
S01GX09	OLOPAT	G	Olopatadine (HCl) - 0.1%	0.1%	Drops solution	524,099 L.L
S01GX09	OLOPAT UD	G	Olopatadine (HCl) - 0.1%	0.1%	Drops solution	1,523,917 L.L
A02BC01	OMEPRAZOLE VIANEX	G	Omeprazole (sodium) - 40mg	40mg	Injectable powder for solution+diluent	467,657 L.L
A02BC01	OMEPRAZOLE-ORBUCELL	G	Omeprazole (sodium) - 40mg	40mg	Injectable solution	3,839,550 L.L
A02BC01	OMEPRAL	G	Omeprazole - 10mg	10mg	Powder for suspension	890,776 L.L
A02BC01	OMEDAR	G	Omeprazole - 20mg	20mg	Tablet, enteric coated	18,087,352 L.L
A02BC01	OMEPRAL	G	Omeprazole - 20mg	20mg	Capsule, delayed release	213,735 L.L
A02BC01	OMEPRAZOLE PHARMADEX	G	Omeprazole - 20mg	20mg	Capsule	415,951 L.L
A02BC01	OMEPRAZOLE PHARMADEX	G	Omeprazole - 20mg	20mg	Capsule	15,757,784 L.L
A02BC01	OMEZOL BENTA	G	Omeprazole - 20mg	20mg	Capsule	550,336 L.L
A02BC01	OMEZOL BENTA	G	Omeprazole - 20mg	20mg	Capsule	317,403 L.L
A02BC01	OMEPRAL	G	Omeprazole - 20mg	20mg	Powder for suspension	712,876 L.L
A02BC01	OMEPRAL	G	Omeprazole - 40mg	40mg	Capsule, delayed release	499,142 L.L
A02BC01	OMEPRAZOLE ARROW	G	Omeprazole - 40mg	40mg	Injectable powder for solution	454,219 L.L
A04AA01	ODNATRON	G	Ondansetron (HCl dihydrate) - 4mg/2ml	4mg/2ml	Injectable solution	880,217 L.L
A04AA01	ONDANSETRON HIKMA	G	Ondansetron (HCl dihydrate) - 4mg/2ml	4mg/2ml	Injectable solution	2,228,091 L.L
A04AA01	ONDANSETRON RENAUDIN	G	Ondansetron (HCl dihydrate) - 4mg/2ml	4mg/2ml	Injectable solution	1,791,342 L.L
A04AA01	ONZO	G	Ondansetron (HCl dihydrate) - 4mg/5ml	4mg/5ml	Solution	2,687,685 L.L
A04AA01	ONDAKEY	G	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, film coated	4,489,778 L.L
A04AA01	ONDANSETRON MEDIS	G	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, film coated	748,520 L.L
A04AA01	ODNATRON	G	Ondansetron (HCl dihydrate) - 8mg/4ml	8mg/4ml	Injectable solution	952,784 L.L
A04AA01	ONDANSETRON HIKMA	G	Ondansetron (HCl dihydrate) - 8mg/4ml	8mg/4ml	Injectable solution	4,018,089 L.L